Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Phosphate binders: new products and challenges.

Antonio Bellasi1, Laura Kooienga, Geoffrey A Block

  • 1Division of Nephrology, San Paolo Hospital, University of Milano, Milano, Italy.

Hemodialysis International. International Symposium on Home Hemodialysis
|June 30, 2006
PubMed
Summary

Managing phosphate levels in dialysis patients remains difficult, despite advances in renal replacement therapy. This review examines phosphate binders and challenges in achieving normal phosphate levels, crucial for patient health.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lipoprotein(a) and Cardiovascular Risk: Emerging Therapeutic Perspectives with Implications for Chronic Kidney Disease.

Cardiorenal medicine·2026
Same author

Unsolved Issues in Managing CKD-Associated Osteoporosis: Myths, Facts, and Clinical Grey Zones.

Kidney360·2026
Same author

Allopurinol and Alkaline Phosphatase Levels in Patients with Non-Dialysis CKD.

Journal of clinical medicine·2026
Same author

Humoral Response to COVID-19 Vaccines and Infection during Sibeprenlimab Treatment of IgA Nephropathy: Data from the ENVISION Trial.

Clinical journal of the American Society of Nephrology : CJASN·2026
Same author

New insights into the management of secondary hyperparathyroidism in non-dialysis dependent chronic kidney disease: extended release calcifediol.

Journal of nephrology·2026
Same author

Modeling Longitudinal Relationships Between CKD-MBD Biomarker Trajectories with Interpretable Machine Learning in a Large Prospective CKD Cohort.

Journal of clinical medicine·2026

Area of Science:

  • Nephrology
  • Mineral Metabolism
  • Dialysis Therapy

Background:

  • Hyperphosphatemia is a significant challenge in dialysis patients.
  • Mineral metabolism imbalances contribute to high mortality rates in renal replacement therapy.
  • Current dialysis techniques have not substantially improved phosphate control.

Purpose of the Study:

  • To review the controversies surrounding phosphate binders.
  • To discuss challenges in achieving normo-phosphatemia.
  • To highlight the importance of optimal phosphate management in dialysis.

Main Methods:

  • Literature review of current phosphate binders.
  • Analysis of challenges in hyperphosphatemia management.
  • Summary of controversies in phosphate control strategies.

Related Experiment Videos

Main Results:

  • Phosphate binders are a cornerstone of hyperphosphatemia management.
  • Significant practical and scientific challenges exist in achieving normo-phosphatemia.
  • Controversies surround the use and efficacy of available phosphate binders.

Conclusions:

  • Optimal phosphate control in dialysis patients is complex.
  • Further research is needed to refine phosphate management strategies.
  • Addressing hyperphosphatemia is critical for improving outcomes in dialysis patients.